The global market for GLP-1 receptor agonists shows a surge in demand due to their effectiveness in managing type 2 diabetes. Several biotechnological companies have received FDA approval to produce these life-changing medications. {Novo Nordisk|Eli Lillyremains a leading producer of GLP-1 receptor agonists, with highly regarded products like c